Lyon PJI Retrospective Cohort Study

Status Recruiting

Clinical Trial Summary

Bone and joint infections (BJI), although infrequent (prevalence of 70 per 100,000 in France), have a significant economic and clinical impact. Between 2008 and 2013, the prevalence of BJI increased and infections involving joint prosthesis (PJI) represent a third of BJI in France. They are most often post-operative and more expensive than native IOAs. This study aims to describe PJI and understand the failure mechanisms of PJI in order to improve their management.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04722926
Study type	Observational
Source	Hospices Civils de Lyon
Contact	Eugenie Mabrut, CRA
Phone	. 04 26 73 29 38
Email	eugenie.mabrut@chu-lyon.fr
Status	Recruiting
Phase
Start date	January 10, 2022
Completion date	March 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05421312` - Periarticular Penetration of Cefazolin and Clindamycin in Second Stage Revision Arthroplasty of the Hip	Phase 4
Active, not recruiting	`NCT04563325` - Oral-only Antibiotics for Bone and Joint Infections in Children	Phase 4
Completed	`NCT03627000` - Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection
Completed	`NCT03311113` - Adherence to Oral Antibiotics In Patients With Osteoarticular Infections
Recruiting	`NCT05753215` - Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection	Phase 2
Completed	`NCT03209921` - Pharmacokinetic Variability of Daptomycin During Prolonged Therapy for Bone and Joint Infections	N/A
Completed	`NCT04418882` - Septic Management and Outcome of Open Fracture
Active, not recruiting	`NCT05248490` - Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home	N/A
Completed	`NCT03624855` - Implant-Associated P. Aeruginosa Bone And Joint Infections : Experience In A Regional Reference Center In France
Recruiting	`NCT04496024` - Ofloxacin Concentration-toxicity Relationship in the Elderly	N/A
Recruiting	`NCT04933344` - Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections
Recruiting	`NCT04538053` - BonE and Joint Infections - Simplifying Treatment in Children Trial	Phase 4
Completed	`NCT04373278` - Infection After Free Fibula Flap Reconstruction of the Mandible: a Retrospective Cohort Study
Completed	`NCT03209934` - Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center	N/A
Recruiting	`NCT02817711` - Lyon BJI Cohort Study	N/A
Recruiting	`NCT03611634` - Consitution Of A Biological Collection From Samples From The Gut Microbiote In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine
Completed	`NCT03177369` - Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration	N/A
Completed	`NCT03852784` - Osteoarticular Infections With Pneumococcal
Recruiting	`NCT03796104` - Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR
Completed	`NCT03848104` - Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint Infections